Get Articles Daily from StraightStocks - Enter Email Address




Business Week’s Gene Marcial’s Stock Picks 7/14/08 Issue

Posted on Friday, July 4th, 2008 | In Current Market News, Stocks to Watch
Contributed by: CEO Blogger (http://ceoblogger.wordpress.com) -

Gene Marcial, Business Week’s Inside Wall Street columnist and stock market guru, recommended the following stocks in the 7/14/08 issue:

1. Mosaic (MOS)

a. Producer of phosphate rock and potash; the prices of fertilizers, such as potash and phosphate, have exploded due to escalating global demand; and the floods in the Midwest and jump in corn plantings are further driving up fertilizer prices boosting Mosaic’s earnings.

b. Mosaic is one of the best ways to play these favorable trends given its leadership in phosphate (No.1) and potash (No.2). And it could use its strong cash flow to initiate a dividend and buy back shares, he says.

2. YRC Worldwide (YRCW)

a. The global transportation giant, which owns Yellow Transportation and Roadway Express, may be on the road to recovery.

b. Some see its operating loss in the first quarter as the cyclical bottom in earnings. If that’s so, says Art Hatfield of Morgan Keegan (which has done banking for YRC), YRC’s results will begin to improve.

c. Analysts are relieved that YRC Chairman and CEO William Zollars on June 17 confirmed his second-quarter profit forecast

3. Access Pharmaceuticals (ACCP) recently signed a licensing pact with Jiangsu Aosaikang Pharmaceutical.

a  Chinese company focused on oncology; they will help develop Access’ No.1 drug, ProLindac, a platinum-based drug for colorectal cancer, now in Phase 2 U.S. trials. Jiangsu will do trials in China, adhering to Food & Drug Administration rules. In return, Access gets $3 million up front and a 20% royalty on ProLindac sales in China.

b.  Access is an enticing buyout target

Track Gene Marcial’s picks at:

http://www.trackthepros.com/categories.php?category_id=404





About CEO Blogger (http://ceoblogger.wordpress.com)
CEOBlogger helps investors evaluate companies.

DISCLAIMER

The commentary on this blog is not meant to be taken as an investment advice. The author is not a registered investment adviser. There is no substitute for your own due diligence. Please be aware that investing is inherently a risky business and if you chose to follow any of the advice on this site, then you are accepting the risks associated with that investment.

The Author may have also taken positions in the stocks that are being discussed and the author may change his position at any time without warning.

With this in mind, I hope you do enjoy the posts and the views presented here and hopefully it generates some profitable ideas for your investments.

Leave a Reply

Name

Email (kept private)

Website








No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.